Geriatric outcomes among older Type 2 diabetic patients treated with DPP4 inhibitors or glinides: focus on sarcopenia markers of muscle and physical performance status (GOOD-WP2)
Latest Information Update: 06 Sep 2023
At a glance
- Drugs Linagliptin (Primary) ; Repaglinide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GOOD-WP2
- 06 Sep 2023 Status changed from recruiting to completed.
- 25 Aug 2021 New trial record